pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
naronapride
Diabetic Gastroparesis
5-hydroxytryptamine receptor 4
Renexxion LLC
0
catalysts
Marketed
natalizumab
Tysabri (natalizumab)
Crohn's Disease (Regional Enteritis)
$BIIB
BIOGEN INC.
0
catalysts
Marketed
natamycin
Natacyn (natamycin)
Blepharitis
$HROW
HARROW, INC.
0
catalysts
← prev
page 198 of 231
next →
131
Pain
89
Neurology
1
Marketed
nateglinide
Nateglinide (nateglinide)
Type 2 Diabetes
Modavar Pharmaceuticals LLC
0
catalysts
Phase 3
navacaprant hydrochloride
Major Depressive Disorder
$NMRA
Neumora Therapeutics, Inc.
0
catalysts
Phase 3
navenibart
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$BCRX
BIOCRYST PHARMACEUTICALS INC
0
catalysts
Phase 2
navicixizumab
Fallopian Tube Cancer
Feng Biosciences Inc
0
catalysts
Phase 3
navitoclax dihydrochloride
Myelofibrosis
$ABBV
AbbVie Inc.
0
catalysts
Phase 2
navtemadlin
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Tumour suppressor p53/oncoprotein Mdm2
Kartos Therapeutics Inc
0
catalysts
Phase 2
naxitamab
Danyelza (naxitamab-gqgk)
Neuroblastoma
Y-mAbs Therapeutics Inc
0
catalysts
Phase 3
naxtarubicin
Refractory Acute Myeloid Leukemia
$MBRX
Moleculin Biotech, Inc.
0
catalysts
Marketed
nebivolol hydrochloride
Nebivolol Hydrochloride (nebivolol hydrochloride)
Hypertension
Beximco Pharmaceuticals USA Inc
0
catalysts
Phase 2
nebokitug
Primary Sclerosing Cholangitis
$CMMB
Chemomab Therapeutics Ltd.
0
catalysts
Marketed
necitumumab
Portrazza (necitumumab)
Squamous Non-Small Cell Lung Cancer
Eli Lilly and Co
0
catalysts
Preclinical
nedaplatin
nedaplatin [INN]
Esophageal Cancer
RNR BioMedical Inc
0
catalysts
Phase 2
nedometinib
Neurofibromatoses Type I (Von Recklinghausen's Disease)
NFlection Therapeutics Inc
0
catalysts
Marketed
nedosiran sodium
Rivfloza (nedosiran sodium)
Primary Hyperoxaluria Type II
L-lactate dehydrogenase A chain mRNA
Novo Nordisk AS
0
catalysts
Marketed
nefazodone hydrochloride
Nefazodone Hydrochloride (nefazodone hydrochloride)
Major Depressive Disorder
Teva Pharmaceuticals USA Inc
0
catalysts
Phase 2
neflamapimod
Frontotemporal Dementia (Pick Disease)
Mitogen-activated protein kinase 14
$CRVO
CervoMed Inc.
0
catalysts
pre_registration
neladalkib
Non-Small Cell Lung Cancer
$NUVL
Nuvalent, Inc.
0
catalysts
Phase 1
neldaleucel
Chronic Lymphocytic Leukemia (CLL)
$MRKR
Marker Therapeutics, Inc.
0
catalysts
Marketed
nelfinavir mesylate
Viracept (nelfinavir mesylate)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$PFE
PFIZER INC
0
catalysts
Phase 2
nemolizumab
Nemluvio (nemolizumab)
Systemic Sclerosis (Scleroderma)
Interleukin-31 receptor subunit alpha
Galderma SA
0
catalysts
Phase 2
nemonoxacin
Taigexyn (nemonoxacin [INN])
Diabetic Foot Infection (DFI)
TaiGen Biotechnology Co Ltd
0
catalysts
Phase 2
nemtabrutinib
Follicular Lymphoma
$MRK
Merck & Co., Inc.
0
catalysts
Marketed
neomycin sulfate
Neomycin Sulfate (neomycin sulfate)
Hepatic Encephalopathy
X-GEN Pharmaceuticals DJB Inc
0
catalysts
Marketed
nepafenac
Ilevro (nepafenac)
Ocular Inflammation
$HROW
HARROW, INC.
0
catalysts
Phase 1
nepicastat hydrochloride
Ulcerative Colitis
Asieris Pharmaceuticals (USA) Inc
0
catalysts
Marketed
neratinib
Nerlynx (neratinib)
Metastatic Brain Tumor
Epidermal growth factor receptor
Receptor tyrosine-protein kinase erbB-2
$PBYI
PUMA BIOTECHNOLOGY, INC.
0
catalysts
Phase 3
neridronic acid
neridronic acid [INN]
Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathet…
Ambros Therapeutics Inc
0
catalysts
